Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?

This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurocritical care 2019-02, Vol.30 (1), p.22-32
Hauptverfasser: Casault, Colin, Al Sultan, Abdulaziz S., Banoei, Mohammad, Couillard, Philippe, Kramer, Andreas, Winston, Brent W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 32
container_issue 1
container_start_page 22
container_title Neurocritical care
container_volume 30
creator Casault, Colin
Al Sultan, Abdulaziz S.
Banoei, Mohammad
Couillard, Philippe
Kramer, Andreas
Winston, Brent W.
description This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), transforming growth factor-β (TGF-β), substance P, and soluble CD40 ligand (sCD40L). A scoping review was undertaken with an electronic search for articles from the Ovid MEDLINE, PUBMED and EMBASE databases from 1995 to 2017. Inclusion criteria were original research articles, and reviews including both animal models and human clinical studies of acute (
doi_str_mv 10.1007/s12028-018-0522-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2018021567</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2018021567</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-a8b12c33647245d6cb416de6108c51b02e5602c1013f9bd9b049a992b152d153</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRrFZ_gBcJePFgdGeS3XS9iBarhYJgC-JpycdU0zZJ3W2E9te7baqC4GFnh5ln3hlexk6AXwLn0ZUF5NjxObgnEP3VDjsAIaTPlYTddR6CL1UQtNihtRPOMVKR2GctVEIqQHXAXrvLRTXNS_Keyc6r0pL18tIb0icZ8kYmrot4kafenYlduV9OarO89l7eN91N7FtvWFRTulhnTamXG7o5YnvjeGbpePu32ah3P-o--oOnh373duCngeos_LiTAKZBIMMIQ5HJNAlBZiSBd1IBCUcSkmMKHIKxSjKV8FDFSmECAjMQQZudN7JzU33UZBe6yG1Ks1lcUlVbjc4djiBk5NCzP-ikqk3pjtOoHCd5FIWOgoZKTWWtobGem7yIzVID12vbdWO7dsJ6bbteuZnTrXKdFJT9THz77ABsAOta5RuZ39X_q34BRf6Kuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920160774</pqid></control><display><type>article</type><title>Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>ProQuest Central</source><creator>Casault, Colin ; Al Sultan, Abdulaziz S. ; Banoei, Mohammad ; Couillard, Philippe ; Kramer, Andreas ; Winston, Brent W.</creator><creatorcontrib>Casault, Colin ; Al Sultan, Abdulaziz S. ; Banoei, Mohammad ; Couillard, Philippe ; Kramer, Andreas ; Winston, Brent W.</creatorcontrib><description>This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), transforming growth factor-β (TGF-β), substance P, and soluble CD40 ligand (sCD40L). A scoping review was undertaken with an electronic search for articles from the Ovid MEDLINE, PUBMED and EMBASE databases from 1995 to 2017. Inclusion criteria were original research articles, and reviews including both animal models and human clinical studies of acute (&lt; 3 months) sTBI. Selected articles included both isolated sTBI and sTBI with systemic injury. After applying the inclusion criteria and removing duplicates, 141 full-text articles, 126 original research articles and 15 review articles, were evaluated in compiling this review paper. A single reviewer, CC, completed the review in two phases. During the first phase, titles and abstracts of selected articles were reviewed for inclusion. A second evaluation was then conducted on the full text of all selected articles to ensure relevancy. From our current understanding of the literature, it is unlikely a single biomarker will be sufficient in accurately prognosticating patients with sTBI. Intuitively, a more severe injury will demonstrate higher levels of inflammatory cytokines which may correlate as a marker of severe injury. This does not mean, necessarily, these cytokines have a direct and causal role in the poor outcome of the patient. Further research is required to better delineate the complex systemic inflammatory and CNS interactions that occur during sTBI before they can be applied as a reliable prognostic tool.</description><identifier>ISSN: 1541-6933</identifier><identifier>EISSN: 1556-0961</identifier><identifier>DOI: 10.1007/s12028-018-0522-z</identifier><identifier>PMID: 29569129</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biomarkers - metabolism ; Brain Injuries, Traumatic - diagnosis ; Brain Injuries, Traumatic - immunology ; Brain Injuries, Traumatic - metabolism ; Critical Care Medicine ; Cytokines - metabolism ; Humans ; Intensive ; Internal Medicine ; Kinases ; Medicine ; Medicine &amp; Public Health ; Mortality ; Neurology ; Review Article ; Traumatic brain injury ; Tumor necrosis factor-TNF</subject><ispartof>Neurocritical care, 2019-02, Vol.30 (1), p.22-32</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2018</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2018.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-a8b12c33647245d6cb416de6108c51b02e5602c1013f9bd9b049a992b152d153</citedby><cites>FETCH-LOGICAL-c398t-a8b12c33647245d6cb416de6108c51b02e5602c1013f9bd9b049a992b152d153</cites><orcidid>0000-0002-3032-1206</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12028-018-0522-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2920160774?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21367,27901,27902,33721,33722,41464,42533,43781,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29569129$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casault, Colin</creatorcontrib><creatorcontrib>Al Sultan, Abdulaziz S.</creatorcontrib><creatorcontrib>Banoei, Mohammad</creatorcontrib><creatorcontrib>Couillard, Philippe</creatorcontrib><creatorcontrib>Kramer, Andreas</creatorcontrib><creatorcontrib>Winston, Brent W.</creatorcontrib><title>Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?</title><title>Neurocritical care</title><addtitle>Neurocrit Care</addtitle><addtitle>Neurocrit Care</addtitle><description>This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), transforming growth factor-β (TGF-β), substance P, and soluble CD40 ligand (sCD40L). A scoping review was undertaken with an electronic search for articles from the Ovid MEDLINE, PUBMED and EMBASE databases from 1995 to 2017. Inclusion criteria were original research articles, and reviews including both animal models and human clinical studies of acute (&lt; 3 months) sTBI. Selected articles included both isolated sTBI and sTBI with systemic injury. After applying the inclusion criteria and removing duplicates, 141 full-text articles, 126 original research articles and 15 review articles, were evaluated in compiling this review paper. A single reviewer, CC, completed the review in two phases. During the first phase, titles and abstracts of selected articles were reviewed for inclusion. A second evaluation was then conducted on the full text of all selected articles to ensure relevancy. From our current understanding of the literature, it is unlikely a single biomarker will be sufficient in accurately prognosticating patients with sTBI. Intuitively, a more severe injury will demonstrate higher levels of inflammatory cytokines which may correlate as a marker of severe injury. This does not mean, necessarily, these cytokines have a direct and causal role in the poor outcome of the patient. Further research is required to better delineate the complex systemic inflammatory and CNS interactions that occur during sTBI before they can be applied as a reliable prognostic tool.</description><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Brain Injuries, Traumatic - diagnosis</subject><subject>Brain Injuries, Traumatic - immunology</subject><subject>Brain Injuries, Traumatic - metabolism</subject><subject>Critical Care Medicine</subject><subject>Cytokines - metabolism</subject><subject>Humans</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mortality</subject><subject>Neurology</subject><subject>Review Article</subject><subject>Traumatic brain injury</subject><subject>Tumor necrosis factor-TNF</subject><issn>1541-6933</issn><issn>1556-0961</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE1Lw0AQhhdRrFZ_gBcJePFgdGeS3XS9iBarhYJgC-JpycdU0zZJ3W2E9te7baqC4GFnh5ln3hlexk6AXwLn0ZUF5NjxObgnEP3VDjsAIaTPlYTddR6CL1UQtNihtRPOMVKR2GctVEIqQHXAXrvLRTXNS_Keyc6r0pL18tIb0icZ8kYmrot4kafenYlduV9OarO89l7eN91N7FtvWFRTulhnTamXG7o5YnvjeGbpePu32ah3P-o--oOnh373duCngeos_LiTAKZBIMMIQ5HJNAlBZiSBd1IBCUcSkmMKHIKxSjKV8FDFSmECAjMQQZudN7JzU33UZBe6yG1Ks1lcUlVbjc4djiBk5NCzP-ikqk3pjtOoHCd5FIWOgoZKTWWtobGem7yIzVID12vbdWO7dsJ6bbteuZnTrXKdFJT9THz77ABsAOta5RuZ39X_q34BRf6Kuw</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Casault, Colin</creator><creator>Al Sultan, Abdulaziz S.</creator><creator>Banoei, Mohammad</creator><creator>Couillard, Philippe</creator><creator>Kramer, Andreas</creator><creator>Winston, Brent W.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3032-1206</orcidid></search><sort><creationdate>20190201</creationdate><title>Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?</title><author>Casault, Colin ; Al Sultan, Abdulaziz S. ; Banoei, Mohammad ; Couillard, Philippe ; Kramer, Andreas ; Winston, Brent W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-a8b12c33647245d6cb416de6108c51b02e5602c1013f9bd9b049a992b152d153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Brain Injuries, Traumatic - diagnosis</topic><topic>Brain Injuries, Traumatic - immunology</topic><topic>Brain Injuries, Traumatic - metabolism</topic><topic>Critical Care Medicine</topic><topic>Cytokines - metabolism</topic><topic>Humans</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mortality</topic><topic>Neurology</topic><topic>Review Article</topic><topic>Traumatic brain injury</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casault, Colin</creatorcontrib><creatorcontrib>Al Sultan, Abdulaziz S.</creatorcontrib><creatorcontrib>Banoei, Mohammad</creatorcontrib><creatorcontrib>Couillard, Philippe</creatorcontrib><creatorcontrib>Kramer, Andreas</creatorcontrib><creatorcontrib>Winston, Brent W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Neurocritical care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casault, Colin</au><au>Al Sultan, Abdulaziz S.</au><au>Banoei, Mohammad</au><au>Couillard, Philippe</au><au>Kramer, Andreas</au><au>Winston, Brent W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?</atitle><jtitle>Neurocritical care</jtitle><stitle>Neurocrit Care</stitle><addtitle>Neurocrit Care</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>30</volume><issue>1</issue><spage>22</spage><epage>32</epage><pages>22-32</pages><issn>1541-6933</issn><eissn>1556-0961</eissn><abstract>This scoping review will discuss the basic functions and prognostic significance of the commonly researched cytokines implicated in severe traumatic brain injury (sTBI), including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), transforming growth factor-β (TGF-β), substance P, and soluble CD40 ligand (sCD40L). A scoping review was undertaken with an electronic search for articles from the Ovid MEDLINE, PUBMED and EMBASE databases from 1995 to 2017. Inclusion criteria were original research articles, and reviews including both animal models and human clinical studies of acute (&lt; 3 months) sTBI. Selected articles included both isolated sTBI and sTBI with systemic injury. After applying the inclusion criteria and removing duplicates, 141 full-text articles, 126 original research articles and 15 review articles, were evaluated in compiling this review paper. A single reviewer, CC, completed the review in two phases. During the first phase, titles and abstracts of selected articles were reviewed for inclusion. A second evaluation was then conducted on the full text of all selected articles to ensure relevancy. From our current understanding of the literature, it is unlikely a single biomarker will be sufficient in accurately prognosticating patients with sTBI. Intuitively, a more severe injury will demonstrate higher levels of inflammatory cytokines which may correlate as a marker of severe injury. This does not mean, necessarily, these cytokines have a direct and causal role in the poor outcome of the patient. Further research is required to better delineate the complex systemic inflammatory and CNS interactions that occur during sTBI before they can be applied as a reliable prognostic tool.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29569129</pmid><doi>10.1007/s12028-018-0522-z</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-3032-1206</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1541-6933
ispartof Neurocritical care, 2019-02, Vol.30 (1), p.22-32
issn 1541-6933
1556-0961
language eng
recordid cdi_proquest_miscellaneous_2018021567
source MEDLINE; Springer Nature - Complete Springer Journals; ProQuest Central
subjects Animals
Biomarkers - metabolism
Brain Injuries, Traumatic - diagnosis
Brain Injuries, Traumatic - immunology
Brain Injuries, Traumatic - metabolism
Critical Care Medicine
Cytokines - metabolism
Humans
Intensive
Internal Medicine
Kinases
Medicine
Medicine & Public Health
Mortality
Neurology
Review Article
Traumatic brain injury
Tumor necrosis factor-TNF
title Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T14%3A13%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine%20Responses%20in%20Severe%20Traumatic%20Brain%20Injury:%20Where%20There%20Is%20Smoke,%20Is%20There%20Fire?&rft.jtitle=Neurocritical%20care&rft.au=Casault,%20Colin&rft.date=2019-02-01&rft.volume=30&rft.issue=1&rft.spage=22&rft.epage=32&rft.pages=22-32&rft.issn=1541-6933&rft.eissn=1556-0961&rft_id=info:doi/10.1007/s12028-018-0522-z&rft_dat=%3Cproquest_cross%3E2018021567%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920160774&rft_id=info:pmid/29569129&rfr_iscdi=true